MedPath

A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy.

Not Applicable
Conditions
Ileostomy patients with abdominal bloating
Registration Number
JPRN-UMIN000016531
Lead Sponsor
Sapporo Higashi Tokushukai Hospital Center for Clinical and Biomedical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with strangulating intestinal obstruction. 2)Patients who are administrated preparation for viable organism within 4 weeks before this study. 3)Patients who was administrated daikenchuto or any Japanese traditional herbal medicine within 4 weeks before this study 4)Virus-positive (HIV, HBV, HCN) 5)Patients have serious coexisting disease (ex. Hepatic distorder, kidney disorder, cardiac disorder, hematological disorder, or metabolic disorder) 6)Women who was lactating or pregnant or person who hope the pregnancy of the partne. 7)Unsuitability as determined by the study doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath